Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
It is designed to test the hypothesis that high loading dose(360mg) ticagrelor versus conventional loading dose(180mg) will result in a higher inhibition of platelet aggregation(IPA) without increasing the bleeding events.
Epistemonikos ID: 1b3977b378693200e97ffc7ebfe727506b756a44
First added on: May 11, 2024